Infectious Diseases (except HIV/AIDS)
-
HAT-field: a cheap, robust and quantitative point-of-care serological test for Covid-19
This article has 2 authors:Reviewed by Review Commons, ScreenIT
-
Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved
This article has 9 authors:Reviewed by ScreenIT
-
A national survey of early treatment seeking behavior among those with incident SARS-CoV-2 infection
This article has 4 authors:Reviewed by ScreenIT
-
The risk of SARS-CoV-2 Omicron variant emergence in low and middle-income countries (LMICs)
This article has 9 authors:Reviewed by ScreenIT
-
Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers
This article has 14 authors:Reviewed by ScreenIT
-
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
This article has 17 authors:Reviewed by ScreenIT
-
Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants
This article has 24 authors:Reviewed by ScreenIT
-
Antigenic evolution of SARS-CoV-2 in immunocompromised hosts
This article has 2 authors:Reviewed by ScreenIT
-
COVID infection severity in children under 5 years old before and after Omicron emergence in the US
This article has 6 authors:Reviewed by ScreenIT
-
Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak
This article has 18 authors:Reviewed by ScreenIT